OCT 11, 2019 3:42 PM PDT

Blood test to detect brain cancer

Research published recently in the journal Nature Communications, a new study details the potential of a blood test that is capable of identifying brain cancer with 87% accuracy. The study was led by Dr. Matthew J. Baker, a reader in the Department of Pure and Applied Chemistry at the University of Strathclyde in Glasgow, United Kingdom.

Brain cancer is a devastating diagnosis to receive, as it comes with a less than 33% chance of a five-year survival rate. However, even getting to the point of receiving a diagnosis is a challenge, as linking the nonspecific symptoms that a brain tumor presents to the actual disease poses quite an obstacle for doctors.

Study co-author Dr. Paul Brennan, who is a senior clinical lecturer and consultant neurosurgeon at the University of Edinburgh in the U.K., commented, "Diagnosing brain tumors is difficult, leading to delays and frustration for lots of [people]. The problem is that symptoms of brain tumor are quite nonspecific, such as headache, or memory problems. It can be difficult for doctors to tell which people are most likely to have a brain tumor.”

In addition to this, the diagnostic tools that we have in place currently are expensive and invasive, making the possibility of a blood test evermore crucial. Dr. Baker says, "This is the first publication of data from our clinical feasibility study, and it is the first demonstration that our blood test works in the clinic."

Brain tumors can be difficult to detect because of nonspecific symptoms like headaches. Photo: Pixabay

In conducting the study, the researchers used a technique called attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy combined with machine learning technology to identify and detect brain cancer. Out of 104 people, the test had an 87% accuracy detection rate.

"With this new test, we have shown that we can help doctors quickly identify which [people] with these nonspecific symptoms should be prioritized for urgent brain imaging," says Dr. Brennan. "This," he adds, "means a more rapid diagnosis for people with a brain tumor and quicker access to treatment."

Sources: Medical News Today, Nature Communications

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAR 21, 2020
Cancer
MAR 21, 2020
Identifying aggressive prostate cancer subtypes
New research published yesterday in the British Journal of Cancer from scientists at the University of East Anglia descr ...
APR 02, 2020
Cancer
APR 02, 2020
Diagnosing Cancer: SMOC2 and Thyroid Cancer
  Thyroid cancer is the most common of the endocrine cancers, with papillary thyroid carcinomas (PTCs) being the mo ...
APR 20, 2020
Cancer
APR 20, 2020
Expanding the Diagnostic Toolkit in Cancer Research with isomiRNAs
Esophageal cancers are one of the more common cancers around the world, with an unfortunately poor prognosis. The five-y ...
APR 27, 2020
Cancer
APR 27, 2020
Talazoparib offers improved quality of life for breast cancer patients
Findings from the Phase III EMBRACA trial have been reported at the American Association for Cancer Research (AACR) annu ...
MAY 07, 2020
Cell & Molecular Biology
MAY 07, 2020
How the Function of a Critical Immune Cell is Related to Metabolism
This work suggests that it may be possible to dampen autoimmunity or promote an immune attack on cancer through a bioche ...
MAY 14, 2020
Drug Discovery & Development
MAY 14, 2020
Therapeutic for Gastrointestinal Tumors
The FDA has approved ripretinib (Qinlock) which is the first drug for fourth-line treatment of advanced gastrointestinal ...
Loading Comments...